The programme is an incubator focused on green sciences, which is tangential to the venture's core AI/biotech drug resistance prediction. The venture's biopharma network and EU location align, but the green sciences theme may dilute relevance. Worth applying if the venture can frame its work as enabling sustainable drug development.